These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 30592714

  • 1. The effects of prednisolone treatment on serological responses and lipid profiles in Ethiopian leprosy patients with Erythema Nodosum Leprosum reactions.
    Negera E, Tilahun M, Bobosha K, Lambert SM, Walker SL, Spencer JS, Aseffa A, Dockrell HM, Lockwood DN.
    PLoS Negl Trop Dis; 2018 Dec; 12(12):e0007035. PubMed ID: 30592714
    [Abstract] [Full Text] [Related]

  • 2. The Effects of Prednisolone Treatment on Cytokine Expression in Patients with Erythema Nodosum Leprosum Reactions.
    Negera E, Walker SL, Bobosha K, Bekele Y, Endale B, Tarekegn A, Abebe M, Aseffa A, Dockrell HM, Lockwood DN.
    Front Immunol; 2018 Dec; 9():189. PubMed ID: 29479352
    [Abstract] [Full Text] [Related]

  • 3. Clinico-pathological features of erythema nodosum leprosum: A case-control study at ALERT hospital, Ethiopia.
    Negera E, Walker SL, Girma S, Doni SN, Tsegaye D, Lambert SM, Idriss MH, Tsegay Y, Dockrell HM, Aseffa A, Lockwood DN.
    PLoS Negl Trop Dis; 2017 Oct; 11(10):e0006011. PubMed ID: 29028793
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. T-cell regulation in Erythema Nodosum Leprosum.
    Negera E, Walker SL, Bobosha K, Howe R, Aseffa A, Dockrell HM, Lockwood DN.
    PLoS Negl Trop Dis; 2017 Oct; 11(10):e0006001. PubMed ID: 28991896
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Alterations in serum lipids in lepromatous leprosy patients with and without ENL reactions and their relationship to acute phase proteins.
    Memon RA, Hussain R, Raynes JG, Lateff A, Chiang TJ.
    Int J Lepr Other Mycobact Dis; 1996 Jun; 64(2):115-22. PubMed ID: 8690968
    [Abstract] [Full Text] [Related]

  • 11. Studies of human leprosy lesions in situ using suction-induced blisters: cell changes with IgM antibody to PGL-1 and interleukin-2 receptor in clinical subgroups of erythema nodosum leprosum.
    Bhoopat L, Scollard DM, Theetranont C, Chiewchanvit S, Nelson DL, Utaipat U.
    Asian Pac J Allergy Immunol; 1991 Dec; 9(2):107-19. PubMed ID: 1807258
    [Abstract] [Full Text] [Related]

  • 12. Whole blood transcriptomics reveals the enrichment of neutrophil activation pathways during erythema nodosum leprosum reaction.
    Rosa TLSA, Leal-Calvo T, Tavares IF, Mendes MA, Dias AA, Piauy MHDS, Barboza MFDS, Kapuscinski M, Costa FDMR, Marques MAM, Belone AFF, Sales AM, Hacker MA, Moreira MBP, Belisle JT, Moraes MO, Pessolani MCV, Schmitz V.
    Front Immunol; 2024 Dec; 15():1366125. PubMed ID: 38715615
    [Abstract] [Full Text] [Related]

  • 13. Toxoplasma gondii infection and high levels of IgE are associated to erythema nodosum leprosy (ENL).
    Nascimento LS, de Castro YS, Figueira JA, Souza RDC, da Silva JA, Nahn EP, Peixoto-Rangel AL.
    PLoS One; 2024 Dec; 19(6):e0300704. PubMed ID: 38865430
    [Abstract] [Full Text] [Related]

  • 14. Complement C1q expression in Erythema nodosum leprosum.
    Negera E, Walker SL, Lema T, Aseffa A, Lockwood DN, Dockrell HM.
    PLoS Negl Trop Dis; 2018 Mar; 12(3):e0006321. PubMed ID: 29499046
    [Abstract] [Full Text] [Related]

  • 15. Immunological status of ENL (erythema nodosum leprosum) patients: its relationship to bacterial load and levels of circulating IL-2R.
    Vieira LM, Sampaio EP, Nery JA, Duppre NC, Albuquerque EC, Scheinberg MA, Sarno EN.
    Rev Inst Med Trop Sao Paulo; 1996 Mar; 38(2):103-11. PubMed ID: 9071029
    [Abstract] [Full Text] [Related]

  • 16. Differential immunoglobulin and complement levels in leprosy prior to development of reversal reaction and erythema nodosum leprosum.
    Amorim FM, Nobre ML, Nascimento LS, Miranda AM, Monteiro GRG, Freire-Neto FP, Queiroz MDCP, Queiroz JW, Duthie MS, Costa MR, Reed SG, Johnson WD, Dupnik KM, Jeronimo SMB.
    PLoS Negl Trop Dis; 2019 Jan; 13(1):e0007089. PubMed ID: 30689631
    [Abstract] [Full Text] [Related]

  • 17. Erythema nodosum leprosum in Nepal: a retrospective study of clinical features and response to treatment with prednisolone or thalidomide.
    Feuth M, Brandsma JW, Faber WR, Bhattarai B, Feuth T, Anderson AM.
    Lepr Rev; 2008 Sep; 79(3):254-69. PubMed ID: 19009975
    [Abstract] [Full Text] [Related]

  • 18. Selective decrease of M. leprae-specific IgG1 and IgG3 antibodies in leprosy patients associated with ENL.
    Kifayet A, Hussain R.
    Int J Lepr Other Mycobact Dis; 1996 Jun; 64(2):105-14. PubMed ID: 8690967
    [Abstract] [Full Text] [Related]

  • 19. Increased serum circulatory levels of interleukin 17F in type 1 reactions of leprosy.
    Chaitanya S, Lavania M, Turankar RP, Karri SR, Sengupta U.
    J Clin Immunol; 2012 Dec; 32(6):1415-20. PubMed ID: 22847545
    [Abstract] [Full Text] [Related]

  • 20. Occurrence of reactions, their diagnosis and management in leprosy patients treated with multidrug therapy; experience in the leprosy control program of the All Africa Leprosy and Rehabilitation Training Center (ALERT) in Ethiopia.
    Becx-Bleumink M, Berhe D.
    Int J Lepr Other Mycobact Dis; 1992 Jun; 60(2):173-84. PubMed ID: 1522359
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.